Why does a high-fat diet induce preeclampsia-like symptoms in pregnant rats?

Neural Regeneration Research

Volumn 8, Issue 20, 2013, Pages 1872-1880

  Ge, Jing ^a,b   Wang, Jun ^b   Xue, Dan ^c   Zhu, Zheng Sheng ^d   Chen, Zhen Yu ^c   Li, Xiao Qiu ^b   Su, Dong Feng ^e   Du, Juan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

^c People's Liberation Army No 202 Hosiptal   (China)

^d Dantu District Sanitary Supervision Institute   (China)

^e The 463 Hospital of Chinese PLA   (China)

Author keywords

Eclampsia; Excitatory neurotransmitter; Grants supported paper; Hyperli pidemia; Hypertension; Lipoprotein associated phospholipase A2; Metabotropic mate receptor 1; Neural regeneration; Neuroregeneration; Neurotoxicity; Preeclampsia; Pregnancy

Indexed keywords

METABOTROPIC RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; ELEVATED BLOOD PRESSURE; FAT INTAKE; FEMALE; HIPPOCAMPUS; LIPID BLOOD LEVEL; LIPID DIET; MALE; NONHUMAN; PREECLAMPSIA; PREGNANCY; PROTEIN EXPRESSION; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TENSION; UPREGULATION; WESTERN BLOTTING;

EID: 84889801306     PISSN: 16735374     EISSN: 18767958     Source Type: Journal    
DOI: 10.3969/j.issn.1673-5374.2013.20.006     Document Type: Article

References (67)

1. Mayret-Mesquiti M, Pérez-Méndez O, Rodríguez ME, et al. Hypertriglyceridemia is linked to reduced nitric oxide syn-thesis in women with hypertensive disorders of pregnancy. Hypertens Pregnancy. 2007;26(4):423-431.
2. Mousa AA, Cappello RE, Estrada-Gutierrez G, et al. Preeclampsia is associated with alterations in DNA me-thylation of genes involved in collagen metabolism. Am J Pathol. 2012;181(4):1455-1463.
3. Chatterjee P, Weaver LE, Doersch KM, et al. Placental Toll-like receptor 3 and Toll-like receptor 7/8 activation contributes to preeclampsia in humans and mice. PLoS One. 2012;7(7):e41884.
4. Jahan P, Sreenivasagari R, Goudi D, et al. Role of Foxp3 gene in maternal susceptibility to pre-eclampsia-a study from South India. Scand J Immunol. 2013;77(2):104-108.
5. Williams D. Long-term complications of preeclampsia. Semin Nephrol. 2011;31(1):111-122.
6. Ghio A, Bertolotto A, Resi V, Volpe L, et al. Triglyceride metabolism in pregnancy. Adv Clin Chem. 2011;55:133-153.
7. Poston L, Igosheva N, Mistry HD, et al. Role of oxidative stress and antioxidant supplementation in pregnancy dis-orders. Am J Clin Nutr. 2011;94(6 Suppl):1980S-1985S.
8. Wang JL, Yang Z, Wang R, et al. Interaction among ab-normal fatty acid oxidation, endothelial function disorder, and oxidative stress in the onset of severe preeclampsia. Zhonghua Yi Xue Za Zhi. 2008;88(21):1471-1475.
9. Adiga U, D'souza V, Kamath A, et al. Antioxidant activity and lipid peroxidation in preeclampsia. J Chin Med Assoc. 2007;70(10):435-438.
10. Chamy VM, Lepe J, Catalán A, et al. Oxidative stress is closely related to clinical severity of pre-eclampsia. Biol Res. 2006;39(2):229-236.
11. Gupta S, Agarwal A, Sharma RK. The role of placental oxidative stress and lipid peroxidation in preeclampsia. Obstet Gynecol Surv. 2005;60(12):807-816.
12. Mackenzie RM, Sandrim VC, Carty DM, et al. Endothelial FOS expression and pre-eclampsia. BJOG. 2012;119(13): 1564-1571.
13. Alijotas-Reig J, Palacio-Garcia C, Llurba E, et al. Cell-derived microparticles and vascular pregnancy complica-tions: a systematic and comprehensive review. Fertil Steril. 2013;99(2):441-449.
14. Masoura S, Kalogiannidis IA, Gitas G, et al. Biomarkers in pre-eclampsia: a novel approach to early detection of the disease. J Obstet Gynaecol. 2012;32(7):609-616.
15. Roes EM, Sieben R, Raijmakers MT, et al. Severe preec-lampsia is associated with a positive family history of hypertension and hypercholesterolemia. Hypertens Pregnancy. 2005;24(3):259-271.
16. Llurba E, Casals E, Domínguez C, et al. Atherogenic li-poprotein subfraction profile in preeclamptic women with and without high triglycerides: different pathophysiologic subsets in preeclampsia. Metabolism. 2005;54(11):1504-1509.
17. Kornacki J, Skrzypczak J. The role of hyperlipidemia and oxidative stress in the etiopathogenesis of pregnan-cy-induced hypertension. Ginekol Pol. 2003;74(2): 168-176.
18. Galley HF, Webster NR. Physiology of the endothelium. Br J Anaesth. 2004;93(1):105-113.
19. Roberts JM, Hubel CA. The two stange model of preec-lampsia: variations on the theme. Placenta. 2009;30 Suppl A:S32-37.
20. Williams D. Long-term complications of preeclampsia. Semin Nephrol. 2011;31(1):111-122.
21. Lima VJ, Andrade CR, Ruschi GE, et al. Serum lipid levels in pregnancies complicated by preeclampsia. Sao Paulo Med J. 2011;129(2):73-76.
22. Baker AM, Klein RL, Moss KL, et al. Maternal serum dys-lipidemia occurs early in pregnancy in women with mild but not severe preeclampsia. Am J Obstet Gynecol. 2009;201(3):293. e1-4.
23. Chen DQ, Zhao HY, Fang Q, et al. Relationship between blood lipid levels of pregnant women with glucose meta-bolism disorders and perinatal outcomes. Zhonghua Fu Chan Ke Za Zhi. 2007;42(6):366-369.
24. Abel T, Blázovics A, Kemény M, et al. Hyperlipoproteinemia in pregnancy. Orv Hetil. 2011;152(19):753-757.
25. Basaran A. Pregnancy-induced hyperlipoproteinemia: review of the literature. Reprod Sci. 2009;16(5):431-437.
26. Saarelainen H, Laitinen T, Raitakari OT, et al. Pregnan-cy-related hyperlipidemia and endothelial function in healthy women. Circ J. 2006;70(6):768-772.
27. Catarino C, Rebelo I, Belo L, et al. Fetal lipoprotein changes in pre-eclampsia. Acta Obstet Gynecol Scand. 2008;87(6):628-634.
28. Ray JG, Diamond P, Singh G, et al. Brief overview of maternal triglycerides as a risk factor for pre-eclampsia. BJOG. 2006;113(4):379-386.
29. Plasm Ware-Jauregui S, Sanchez SE, Zhang C, et al. Plasma lipid concentrations in pre-eclamptic and normo-tensive Peruvian women. Int J Gynaecol Obstet. 1999;67(3):147-155.
30. Thomson LM, Zeng J, Terman GW. An N-methyl-D-aspartate receptor mediated large, low-frequency, spontaneous excitatory postsynaptic cur-rent in neonatal rat spinal dorsal horn neurons. Neuros-cience. 2006;141(3): 1489-1501.
31. Ferando I, Mody I. GABAA receptor modulation by neu-rosteroids in models of temporal lobe epilepsies. Epilepsia. 2012;53 Suppl 9:89-101.
32. Deeb TZ, Maguire J, Moss SJ. Possible alterations in GABAA receptor signaling that underlie benzodiaze-pine-resistant seizures. Epilepsia. 2012;53 Suppl 9: 79-88.
33. Ronne-Engstrom E, Hillered L, Flink R, et al. Intracerebral microdialysis of extracellular amino acids in the human epileptic focus. Cereb Blood Flow Metab. 1992;12:873-876.
34. Li DP, Pan HL. Increased group I metabotropic glutamate receptor activity in paraventricular nucleus supportsele-vated sympathetic vasomotor tone in hypertension. Am J Physiol Regul Integr Comp Physiol. 2010;299(2): R552-561.
35. Pitsch J, Schoch S, Gueler N, et al. Functional role of mGluR1 and mGluR4 in pilocarpine-induced temporal lobe epilepsy. Neurobiol Dis. 2007;26(3):623-633.
36. Mares P. Age-dependent anticonvulsant action of anta-gonists of group I glutamate metabotropic receptors in rats. Epilepsy Res. 2009;83(2-3):215-223.
37. Shannon HE, Peters SC, Kingston AE. Anticonvulsant effects of LY456236, a selective mGlu1 receptor anta-gonist. Neuropharmacology. 2005;49 Suppl 1:188-195.
38. Karr L, Rutecki PA. Activity-dependent induction and maintenance of epileptiform activity produced by group I metabotropic glutamate receptors in the rat hippocampal slice. Epilepsy Res. 2008;81(1):14-23.
39. Imamura S, Tanaka S, Akaike K, et al. Hippocampal transection attenuates kainic acid-induced amygdalar seizures in rats. Brain Res. 2001;897(1-2):93-103.
40. Masuyama H, Hiramatsu Y. Treatment with a constitutive androstane receptor ligand ameliorates the signs of preeclampsia in high-fat diet-induced obese pregnant mice. Mol Cell Endocrinol. 2012;348(1):120-127.
41. Wilde DW, Massey KD, Walker GK, et al. High-fat diet elevates blood pressure and cerebrovascular muscle Ca(2+) current. Hypertension. 2000;35(3):832-837.
42. Kashyap SR, Belfort R, Cersosimo E, et al. Chronic low-dose lipid infusion in healthy patients inducesmarkers of endothelial activation independent of its metabolic effects. Cardiometab Syndr. 2008;3 (3):141.
43. Yang F, Cai W, Yang K, et al. PKCδ knockdown inhibits free fatty acid induction of endothelial cell apoptosis. Cell Biochem Funct. in press.
44. Knapp A, Czech U, Góralska J, et al. Influence of fatty acids on mitochondrial metabolism of adipocyte progenitors and endothelial cells. Arch Physiol Biochem. 2012; 118(3):128-134.
45. Wang L, Lim EJ, Toborek M, et al. The role of fatty acids and caveolin-1 in tumor necrosis factor alpha-induced endothelial cell activation. Metabolism. 2008;57(10): 1328-1339.
46. Boden G. Obesity and free fatty acids. Endocrinol Metab Clin North Am. 2008;37(3):635-46, viii-ix.
47. Villa PM, Laivuori H, Kajantie E, et al. Free fatty acid profiles in preeclampsia. Prostaglandins Leukot Essent Fatty Acids. 2009;81(1):17-21.
48. Robinson NJ, Minchell LJ, Myers JE, et al. A potential role for free fatty acids in the pathogenesis of preeclampsia. J Hypertens. 2009;27(6):1293-1302.
49. Moutzouri E, Tsimihodimos V, Tselepis AD. Inflammatory biomarkers and cardiovascular risk assessment. Current knowledge and future perspectives. Curr Pharm Des. in press.
50. Zhang H, Zhang JY, Sun TW, et al. Amelioration of athe-rosclerosis in apolipoprotein E-deficient mice by inhibition of lipoprotein-associated phospholipase A2. Clin Invest Med. 2013;36(1):E32-41.
51. Paik JK, Chae JS, Jang Y, et al. Effects of V279F in the Lp-PLA(2) gene on markers of oxidative stress and in-flammation in Koreans. Clin Chim Acta. 2010;411(7-8): 486-493.
52. Wang T, Karino K, Yamasaki M, et al. Effects of G994T in the Lp-PLA2 gene on the plasma oxidized LDL level and carotid intima-media thickness in Japanese: the Shimane study. Am J Hypertens. 2009;22(7):742-747.
53. Rosenson RS. Fenofibrate reduces lipoprotein associated phospholipase A2 mass and oxidative lipids in hypertrig-lyceridemic subjects with the metabolic syndrome. Am Heart J. 2008;155(3):499. e9-16.
54. Dullaart RP, Constantinides A, Perton FG, et al. Plasma cholesteryl ester transfer, but not cholesterol esterification, is related to lipoprotein-associated phospholipase A2: possible contribution to an atherogenic lipoprotein profile. J Clin Endocrinol Metab. 2011;96(4):1077-1084.
55. Sertić J, Skorić B, Lovrić J, et al. Does Lp-PLA2 determi-nation help predict atherosclerosis and cardiocerebro-vascular disease? Acta Med Croatica. 2010;64(4): 237-245.
56. Brilakis ES, Joseph P, McConnell JP, et al. Higher levels of lipoprotein-associated phospholipase A2 are asso-ciated with higher incidence of cardiovascular events at follow up independent of C-reactive protein. Eur Heart J. 2004;26:137-144.
57. Robins SJ, Collins D, Nelson JJ, et al. Cardiovascular events with increased lipoprotein-associated phospholi-pase A(2), and low high-density lipoprotein-cholesterol: the Veterans Affairs HDL Intervention Trial. Arterioscler Thromb Vasc Biol. 2008;28(6):1172-1178.
58. Davidson MH, Corson MA, Alberts MJ, et al. Consensus panel recommendation for incorporating lipoprotein asso-ciated phospholipase A2 testing into cardiovascular dis-ease risk assessment guidelines. Am J Cardiol. 2008; 101(12A):51F-55F.
59. Oei HH, van der Meer IM, Hofman A, et al. Lipoprote-in-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study. Circulation. 2005;111(5):570-575.
60. Wassertheil-Smoller S, Kooperberg C, McGinn AP, et al. Lipoprotein-associated phospholipase A2, hormone use, and the risk of ischemic stroke in postmenopausal women. Hypertension. 2008;51(4):1115-1122.
61. Gu Y, Burlison SA, Wang Y. PAF levels and PAF-AH ac-tivities in placentas from normal and preeclamptic preg-nancies. Placenta. 2006;27(6-7):744-749.
62. Fan P, Liu XH, He GL, et al. Maternal and fetal plasma platelet-activating factor acetylhydrolase activity and dis-tribution in pre-eclampsia. Pediatr Res. 2012;72(4):426-431.
63. The Ministry of Science and Technology of the People's Republic of China. Guidance Suggestions for the Care and Use of Laboratory Animals. 2006-09-30.
64. Dilena BA, Penberthy LA, Fraser CG. Six methods for determining urinary protein compared. Clin Chem. 1983; 29(3):553-557.
65. Shaodong C, Haihong Z, Manting L, et al. Research of influence and mechanism of combining exercise with diet control on a model of lipid metabolism rat induced by high fat diet. Lipids Health Dis. 2013;12:21.
66. Bradford MM. A rapid and sensitive method for the quan-titation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72: 248-254.
67. Guo F, Sun F, Yu JL, et al. Abnormal expressions of glu-tamate transporters and metabotropic glutamate receptor 1 in the spontaneously epileptic rat hippocampus. Brain Res Bull. 2010;81(4-5):510-516.